Skip to main content
Top
Published in: Respiratory Research 1/2014

Open Access 01-12-2014 | Research

Observational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS study

Authors: Marc Miravitlles, Heinrich Worth, Juan José Soler Cataluña, David Price, Fernando De Benedetto, Nicolas Roche, Nina Skavlan Godtfredsen, Thys van der Molen, Claes-Göran Löfdahl, Laura Padullés, Anna Ribera

Published in: Respiratory Research | Issue 1/2014

Login to get access

Abstract

Background

Few studies have investigated the 24-hour symptom profile in patients with COPD or how symptoms during the 24-hour day are inter-related. This observational study assessed the prevalence, severity and relationship between night-time, early morning and daytime COPD symptoms and explored the relationship between 24-hour symptoms and other patient-reported outcomes.

Methods

The study enrolled patients with stable COPD in clinical practice. Baseline night-time, early morning and daytime symptoms (symptom questionnaire), severity of airflow obstruction (FEV1), dyspnoea (modified Medical Research Council Dyspnoea Scale), health status (COPD Assessment Test), anxiety and depression levels (Hospital Anxiety and Depression Scale), sleep quality (COPD and Asthma Sleep Impact Scale) and physical activity level (sedentary, moderately active or active) were recorded.

Results

The full analysis set included 727 patients: 65.8% male, mean ± standard deviation age 67.2 ± 8.8 years, % predicted FEV1 52.8 ± 20.5%.
In each part of the 24-hour day, >60% of patients reported experiencing ≥1 symptom in the week before baseline. Symptoms were more common in the early morning and daytime versus night-time (81.4%, 82.7% and 63.0%, respectively). Symptom severity was comparable for each period assessed. Overall, in the week before baseline, 56.7% of patients had symptoms throughout the whole 24-hour day (3 parts of the day); 79.9% had symptoms in ≥2 parts of the 24-hour day. Symptoms during each part of the day were inter-related, irrespective of disease severity (all p < 0.001).
Early morning and daytime symptoms were associated with the severity of airflow obstruction (p < 0.05 for both). Night-time, early morning and daytime symptoms were all associated with worse dyspnoea, health status and sleep quality, and higher anxiety and depression levels (all p < 0.001 versus patients without symptoms in each corresponding period). In each part of the 24-hour day, there was also an association between symptoms and a patient’s physical activity level (p < 0.05 for each period).

Conclusions

More than half of patients experienced COPD symptoms throughout the whole 24-hour day. There was a significant relationship between night-time, early morning and daytime symptoms. In each period, symptoms were associated with worse patient-reported outcomes, suggesting that improving 24-hour symptoms should be an important consideration in the management of COPD.
Appendix
Available only for authorised users
Literature
1.
go back to reference Decramer M, Janssens W, Miravitlles M: Chronic obstructive pulmonary disease. Lancet. 2012, 379: 1341-1351. 10.1016/S0140-6736(11)60968-9.PubMedCrossRef Decramer M, Janssens W, Miravitlles M: Chronic obstructive pulmonary disease. Lancet. 2012, 379: 1341-1351. 10.1016/S0140-6736(11)60968-9.PubMedCrossRef
2.
go back to reference van der Molen T: Co-morbidities of COPD in primary care: frequency, relation to COPD, and treatment consequences. Prim Care Respir J. 2010, 19: 326-334. 10.4104/pcrj.2010.00053.PubMedCrossRef van der Molen T: Co-morbidities of COPD in primary care: frequency, relation to COPD, and treatment consequences. Prim Care Respir J. 2010, 19: 326-334. 10.4104/pcrj.2010.00053.PubMedCrossRef
3.
go back to reference Waatevik M, Skorge TD, Omenaas E, Bakke PS, Gulsvik A, Johannessen A: Increased prevalence of chronic obstructive pulmonary disease in a general population. Respir Med. 2013, 107: 1037-1045. 10.1016/j.rmed.2013.04.008.PubMedCrossRef Waatevik M, Skorge TD, Omenaas E, Bakke PS, Gulsvik A, Johannessen A: Increased prevalence of chronic obstructive pulmonary disease in a general population. Respir Med. 2013, 107: 1037-1045. 10.1016/j.rmed.2013.04.008.PubMedCrossRef
4.
go back to reference Miravitlles M, Anzueto A, Legnani D, Forstmeier L, Fargel M: patient’s perception of exacerbations of COPD-the PERCEIVE study. Respir Med. 2007, 101: 453-460. 10.1016/j.rmed.2006.07.010.PubMedCrossRef Miravitlles M, Anzueto A, Legnani D, Forstmeier L, Fargel M: patient’s perception of exacerbations of COPD-the PERCEIVE study. Respir Med. 2007, 101: 453-460. 10.1016/j.rmed.2006.07.010.PubMedCrossRef
5.
go back to reference Tsiligianni I, Kocks J, Tzanakis N, Siafakas N, van der Molen T: Factors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlations. Prim Care Respir J. 2011, 20: 257-268. 10.4104/pcrj.2011.00029.PubMedCrossRef Tsiligianni I, Kocks J, Tzanakis N, Siafakas N, van der Molen T: Factors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlations. Prim Care Respir J. 2011, 20: 257-268. 10.4104/pcrj.2011.00029.PubMedCrossRef
6.
go back to reference Monteagudo M, Rodriguez-Blanco T, Llagostera M, Valero C, Bayona X, Ferrer M, Miravitlles M: Factors associated with changes in quality of life of COPD patients: a prospective study in primary care. Respir Med. 2013, 107: 1589-1597. 10.1016/j.rmed.2013.05.009.PubMedCrossRef Monteagudo M, Rodriguez-Blanco T, Llagostera M, Valero C, Bayona X, Ferrer M, Miravitlles M: Factors associated with changes in quality of life of COPD patients: a prospective study in primary care. Respir Med. 2013, 107: 1589-1597. 10.1016/j.rmed.2013.05.009.PubMedCrossRef
7.
go back to reference Price D, Small M, Milligan G, Higgins V, Garcia Gil E, Estruch J: Impact of night-time symptoms in COPD: a real-world study in five European countries. Int J Chron Obstruct Pulmon Dis. 2013, 8: 595-603. 10.2147/COPD.S48570.PubMedPubMedCentralCrossRef Price D, Small M, Milligan G, Higgins V, Garcia Gil E, Estruch J: Impact of night-time symptoms in COPD: a real-world study in five European countries. Int J Chron Obstruct Pulmon Dis. 2013, 8: 595-603. 10.2147/COPD.S48570.PubMedPubMedCentralCrossRef
8.
go back to reference Roche N, Chavannes NH, Miravitlles M: COPD symptoms in the morning: impact, evaluation and management. Respir Res. 2013, 14: 112-10.1186/1465-9921-14-112.PubMedPubMedCentralCrossRef Roche N, Chavannes NH, Miravitlles M: COPD symptoms in the morning: impact, evaluation and management. Respir Res. 2013, 14: 112-10.1186/1465-9921-14-112.PubMedPubMedCentralCrossRef
9.
go back to reference Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013, 187: 347-365. 10.1164/rccm.201204-0596PP.PubMedCrossRef Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013, 187: 347-365. 10.1164/rccm.201204-0596PP.PubMedCrossRef
10.
go back to reference Kessler R, Partridge MR, Miravitlles M, Cazzola M, Vogelmeier C, Leynaud D, Ostinelli J: Symptom variability in patients with severe COPD: a pan-European cross-sectional study. Eur Respir J. 2011, 37: 264-272. 10.1183/09031936.00051110.PubMedCrossRef Kessler R, Partridge MR, Miravitlles M, Cazzola M, Vogelmeier C, Leynaud D, Ostinelli J: Symptom variability in patients with severe COPD: a pan-European cross-sectional study. Eur Respir J. 2011, 37: 264-272. 10.1183/09031936.00051110.PubMedCrossRef
11.
go back to reference Espinosa de los Monteros MJ, Pena C, Soto Hurtado EJ, Jareno J, Miravitlles M: Variability of respiratory symptoms in severe COPD. Arch Bronconeumol. 2012, 48: 3-7. 10.1016/j.arbres.2011.07.004.PubMedCrossRef Espinosa de los Monteros MJ, Pena C, Soto Hurtado EJ, Jareno J, Miravitlles M: Variability of respiratory symptoms in severe COPD. Arch Bronconeumol. 2012, 48: 3-7. 10.1016/j.arbres.2011.07.004.PubMedCrossRef
12.
go back to reference Partridge MR, Karlsson N, Small IR: Patient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet survey. Curr Med Res Opin. 2009, 25: 2043-2048. 10.1185/03007990903103006.PubMedCrossRef Partridge MR, Karlsson N, Small IR: Patient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet survey. Curr Med Res Opin. 2009, 25: 2043-2048. 10.1185/03007990903103006.PubMedCrossRef
13.
go back to reference Roche N, Small M, Broomfield S, Higgins V, Pollard R: Real world COPD: association of morning symptoms with clinical and patient reported outcomes. COPD. 2013, 10: 679-686. 10.3109/15412555.2013.844784.PubMedCrossRef Roche N, Small M, Broomfield S, Higgins V, Pollard R: Real world COPD: association of morning symptoms with clinical and patient reported outcomes. COPD. 2013, 10: 679-686. 10.3109/15412555.2013.844784.PubMedCrossRef
14.
go back to reference Lange P, Marott JL, Vestbo J, Nordestgaard BG: Prevalence of night-time dyspnoea in COPD and its implications for prognosis. Eur Respir J. 2014, 43: 1590-1598. 10.1183/09031936.00196713.PubMedCrossRef Lange P, Marott JL, Vestbo J, Nordestgaard BG: Prevalence of night-time dyspnoea in COPD and its implications for prognosis. Eur Respir J. 2014, 43: 1590-1598. 10.1183/09031936.00196713.PubMedCrossRef
16.
go back to reference Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA: Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999, 54: 581-586. 10.1136/thx.54.7.581.PubMedPubMedCentralCrossRef Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA: Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999, 54: 581-586. 10.1136/thx.54.7.581.PubMedPubMedCentralCrossRef
17.
go back to reference Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline LN: Development and first validation of the COPD Assessment Test. Eur Respir J. 2009, 34: 648-654. 10.1183/09031936.00102509.PubMedCrossRef Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline LN: Development and first validation of the COPD Assessment Test. Eur Respir J. 2009, 34: 648-654. 10.1183/09031936.00102509.PubMedCrossRef
18.
go back to reference Hemmann C: International experiences with the hospital anxiety and depression scale - a review of validation data and clinical results. J Psychosom Res. 1997, 42: 17-41. 10.1016/S0022-3999(96)00216-4.CrossRef Hemmann C: International experiences with the hospital anxiety and depression scale - a review of validation data and clinical results. J Psychosom Res. 1997, 42: 17-41. 10.1016/S0022-3999(96)00216-4.CrossRef
19.
go back to reference Snaith R: The Hospital Anxiety and Depression (HADS) scale. Qual Life Newsletter. 1993, 6: 5-6. Snaith R: The Hospital Anxiety and Depression (HADS) scale. Qual Life Newsletter. 1993, 6: 5-6.
20.
go back to reference White D, Leach C, Sims R, Atkinson M, Cottrell D: Validation of the hospital anxiety and depression scale for use with adolescents. Br J Psychiatry. 1999, 175: 452-454. 10.1192/bjp.175.5.452.PubMedCrossRef White D, Leach C, Sims R, Atkinson M, Cottrell D: Validation of the hospital anxiety and depression scale for use with adolescents. Br J Psychiatry. 1999, 175: 452-454. 10.1192/bjp.175.5.452.PubMedCrossRef
21.
go back to reference Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983, 67: 361-370. 10.1111/j.1600-0447.1983.tb09716.x.PubMedCrossRef Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983, 67: 361-370. 10.1111/j.1600-0447.1983.tb09716.x.PubMedCrossRef
22.
go back to reference Bjelland I, Dahl AA, Haug TT, Neckelmann D: The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res. 2002, 52: 69-77. 10.1016/S0022-3999(01)00296-3.PubMedCrossRef Bjelland I, Dahl AA, Haug TT, Neckelmann D: The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res. 2002, 52: 69-77. 10.1016/S0022-3999(01)00296-3.PubMedCrossRef
23.
go back to reference Olsson I, Mykletun A, Dahl AA: The hospital anxiety and depression rating scale: a cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry. 2005, 5: 46-10.1186/1471-244X-5-46.PubMedPubMedCentralCrossRef Olsson I, Mykletun A, Dahl AA: The hospital anxiety and depression rating scale: a cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry. 2005, 5: 46-10.1186/1471-244X-5-46.PubMedPubMedCentralCrossRef
24.
go back to reference Pokrzywinski RF, Meads DM, McKenna SP, Glendenning GA, Revicki DA: Development and psychometric assessment of the COPD and Asthma Sleep Impact Scale (CASIS). Health Qual Life Outcomes. 2009, 7: 98-10.1186/1477-7525-7-98.PubMedPubMedCentralCrossRef Pokrzywinski RF, Meads DM, McKenna SP, Glendenning GA, Revicki DA: Development and psychometric assessment of the COPD and Asthma Sleep Impact Scale (CASIS). Health Qual Life Outcomes. 2009, 7: 98-10.1186/1477-7525-7-98.PubMedPubMedCentralCrossRef
25.
go back to reference Miravitlles M, Iriberri M, Barrueco M, Lleonart M, Villarrubia E, Galera J: Usefulness of the LCOPD, CAFS and CASIS scales in understanding the impact of COPD on patients. Respiration. 2013, 86: 190-200. 10.1159/000341175.PubMedCrossRef Miravitlles M, Iriberri M, Barrueco M, Lleonart M, Villarrubia E, Galera J: Usefulness of the LCOPD, CAFS and CASIS scales in understanding the impact of COPD on patients. Respiration. 2013, 86: 190-200. 10.1159/000341175.PubMedCrossRef
26.
go back to reference Agusti A, Hedner J, Marin JM, Barbé F, Cazzola M, Rennard S: Night-time symptoms: a forgotten dimension of COPD. Eur Respir Rev. 2011, 20: 183-194. 10.1183/09059180.00004311.PubMedCrossRef Agusti A, Hedner J, Marin JM, Barbé F, Cazzola M, Rennard S: Night-time symptoms: a forgotten dimension of COPD. Eur Respir Rev. 2011, 20: 183-194. 10.1183/09059180.00004311.PubMedCrossRef
27.
go back to reference Spengler CM, Shea SA: Endogenous circadian rhythm of pulmonary function in healthy humans. Am J Respir Crit Care Med. 2000, 162: 1038-1046. 10.1164/ajrccm.162.3.9911107.PubMedCrossRef Spengler CM, Shea SA: Endogenous circadian rhythm of pulmonary function in healthy humans. Am J Respir Crit Care Med. 2000, 162: 1038-1046. 10.1164/ajrccm.162.3.9911107.PubMedCrossRef
28.
go back to reference Postma DS, Koëter GH, vd Mark TW, Reig RP, Sluiter HJ: The effects of oral slow-release terbutaline on the circadian variation in spirometry and arterial blood gas levels in patients with chronic airflow obstruction. Chest. 1985, 87: 653-657. 10.1378/chest.87.5.653.PubMedCrossRef Postma DS, Koëter GH, vd Mark TW, Reig RP, Sluiter HJ: The effects of oral slow-release terbutaline on the circadian variation in spirometry and arterial blood gas levels in patients with chronic airflow obstruction. Chest. 1985, 87: 653-657. 10.1378/chest.87.5.653.PubMedCrossRef
29.
go back to reference Casale R, Pasqualetti P: Cosinor analysis of circadian peak expiratory flow variability in normal subjects, passive smokers, heavy smokers, patients with chronic obstructive pulmonary disease and patients with interstitial lung disease. Respiration. 1997, 64: 251-256. 10.1159/000196682.PubMedCrossRef Casale R, Pasqualetti P: Cosinor analysis of circadian peak expiratory flow variability in normal subjects, passive smokers, heavy smokers, patients with chronic obstructive pulmonary disease and patients with interstitial lung disease. Respiration. 1997, 64: 251-256. 10.1159/000196682.PubMedCrossRef
30.
go back to reference Kon SS, Canavan JL, Jones SE, Nolan CM, Clark AL, Dickson MJ, Haselden BM, Polkey MI, Man WD: Minimum clinically important difference for the COPD Assessment Test: a prospective analysis. Lancet Respir Med. 2014, 2: 195-203. 10.1016/S2213-2600(14)70001-3.PubMedCrossRef Kon SS, Canavan JL, Jones SE, Nolan CM, Clark AL, Dickson MJ, Haselden BM, Polkey MI, Man WD: Minimum clinically important difference for the COPD Assessment Test: a prospective analysis. Lancet Respir Med. 2014, 2: 195-203. 10.1016/S2213-2600(14)70001-3.PubMedCrossRef
31.
go back to reference van Manen JG, Bindels PJ, Dekker FW, IJzermans CJ, van der Zee JS, Schade E: Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax. 2002, 57: 412-416. 10.1136/thorax.57.5.412.PubMedPubMedCentralCrossRef van Manen JG, Bindels PJ, Dekker FW, IJzermans CJ, van der Zee JS, Schade E: Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax. 2002, 57: 412-416. 10.1136/thorax.57.5.412.PubMedPubMedCentralCrossRef
32.
go back to reference Atlantis E, Fahey P, Cochrane B, Smith S: Bidirectional associations between clinically relevant depression or anxiety and COPD: a systematic review and meta-analysis. Chest. 2013, 144: 766-777. 10.1378/chest.12-1911.PubMedCrossRef Atlantis E, Fahey P, Cochrane B, Smith S: Bidirectional associations between clinically relevant depression or anxiety and COPD: a systematic review and meta-analysis. Chest. 2013, 144: 766-777. 10.1378/chest.12-1911.PubMedCrossRef
33.
go back to reference Scharf SM, Maimon N, Simon-Tuval T, Bernhard-Scharf BJ, Reuveni H, Tarasiuk A: Sleep quality predicts quality of life in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2011, 6: 1-12.PubMedCentral Scharf SM, Maimon N, Simon-Tuval T, Bernhard-Scharf BJ, Reuveni H, Tarasiuk A: Sleep quality predicts quality of life in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2011, 6: 1-12.PubMedCentral
34.
go back to reference Miravitlles M, Cantoni J, Naberan K: Factors associated with a low level of physical activity in patients with chronic obstructive pulmonary disease. Lung. 2014, 192: 259-265. 10.1007/s00408-014-9557-x.PubMedCrossRef Miravitlles M, Cantoni J, Naberan K: Factors associated with a low level of physical activity in patients with chronic obstructive pulmonary disease. Lung. 2014, 192: 259-265. 10.1007/s00408-014-9557-x.PubMedCrossRef
35.
go back to reference Waschki B, Kirsten A, Holz O, Muller KC, Meyer T, Watz H, Magnussen H: Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest. 2011, 140: 331-342. 10.1378/chest.10-2521.PubMedCrossRef Waschki B, Kirsten A, Holz O, Muller KC, Meyer T, Watz H, Magnussen H: Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest. 2011, 140: 331-342. 10.1378/chest.10-2521.PubMedCrossRef
36.
go back to reference Garcia-Rio F, Rojo B, Casitas R, Lores V, Madero R, Romero D, Galera R, Villasante C: Prognostic value of the objective measurement of daily physical activity in patients with COPD. Chest. 2012, 142: 338-346. 10.1378/chest.1388806.PubMedCrossRef Garcia-Rio F, Rojo B, Casitas R, Lores V, Madero R, Romero D, Galera R, Villasante C: Prognostic value of the objective measurement of daily physical activity in patients with COPD. Chest. 2012, 142: 338-346. 10.1378/chest.1388806.PubMedCrossRef
Metadata
Title
Observational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS study
Authors
Marc Miravitlles
Heinrich Worth
Juan José Soler Cataluña
David Price
Fernando De Benedetto
Nicolas Roche
Nina Skavlan Godtfredsen
Thys van der Molen
Claes-Göran Löfdahl
Laura Padullés
Anna Ribera
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2014
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/s12931-014-0122-1

Other articles of this Issue 1/2014

Respiratory Research 1/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.